Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Check against the official notice below — it lists the full affected range.
Golden State Medical Supply Inc. is recalling Enalapril Maleate Tablets, USP 5 mg in 90-tablet bottles due to Current Good Manufacturing Practice (CGMP) deviations. The recalled product was manufactured by Taro Pharmaceutical Industries, Ltd. and packaged by GSMS, Incorporated in California. A total of 9,058 units were distributed nationwide across Pennsylvania, Massachusetts, Ohio, Texas, Illinois, North Dakota, and Hawaii, with multiple lot numbers and expiration dates ranging from September 2022 through March 2024.
The specific lot numbers affected include GS029041, GS029353, GS02986, GS030056, GS030869, GS033943, GS034490, GS035197, GS035198, GS035596, GS035947, GS036759, GS037400, GS038089, GS038763, GS039559, GS040150, GS040151, GS040708, GS041107, and GS041654. The recall notice does not specify a remedy or recommended action for consumers who may have this medication.
Written by software from the official notice below. Not reviewed by a lawyer.
CGMP Deviations
Reason for recall: CGMP Deviations Distribution: Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI Quantity: 9,058 Lot/code info: Lot: GS029041, GS029353, GS02986, 5 mg; 90 tablets, Exp.: 09/2022; Lot: GS030056, GS030869, GS033943, Exp.: 10/2022; Lots: GS034490, GS035197, Exp.:02/2023; Lots: GS035198, Exp.: 03/2023; Lots: GS035596, GS035947, GS036759, GS037400, Exp.: 06/2023; Lots: GS038089, GS038763, GS039559, GS040150, Exp.: 10/2023; Lots: GS040151, GS040708, GS041107, Exp.: 12/2023; Lot: GS041654, Exp.: 03/2024.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.